Error: Could not add to watchlist. X

CytRx Corp

+ Watchlist
CYTR:US
NASDAQ CM
3.66
USD
0.06
1.61%
As of 20:10:00 ET on 07/03/2015.
Open
3.72
Day Range
3.62 - 3.77
Volume
297,179
Previous Close
3.72
52Wk Range
2.08 - 5.42
1 Yr Return
-10.07%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.94
Market Cap (m USD)
203.945
Shares Outstanding (m)
55.723
Price/Sales (TTM)
1,977.01
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
CytRx Corporation is a biopharmaceutical research and development company. The Company focuses in the development of high-value human therapeutics, specializing in oncology. CytRx is also developing two drug candidates based on its molecular chaperone regulation technology.
ADDRESS
11726 San Vicente Boulevard
Suite 650
Los Angeles, CA 90049
United States
PHONE
1-310-826-5648
  • Steven A Kriegsman
    President/CEO
  • Jean-Yves Caloz "John"
    CFO/Treasurer
  • Daniel J Levitt
    Exec VP/Chief Medical Officer
  • Benjamin S Levin
    Senior VP/Secy/General Counsel
  • Scott Wieland
    Senior VP:Drug Development
Show More